NCT07289945

Brief Summary

The goal of this clinical study is to compare the effects of desflurane versus sevoflurane on early postoperative recovery and cognitive function in elderly patients (aged 60 years and older, ASA I-III) undergoing elective non-cardiac surgery under general anesthesia. The main questions this study aims to answer are: Which anesthetic agent allows faster emergence from anesthesia (eye opening, response to commands, extubation)? Does desflurane lead to earlier cognitive recovery as measured by the Short Orientation Memory Concentration Test (SOMCT)? Does the choice of volatile anesthetic influence the time required to achieve a modified Aldrete score (MAS) ≥ 9 and PACU discharge readiness? Researchers compared the desflurane group to the sevoflurane group to determine whether desflurane provides a superior recovery profile and minimizes delayed emergence in elderly surgical patients. Participants will: Be randomly assigned to receive either desflurane or sevoflurane for maintenance of general anesthesia. Undergo standardized induction with fentanyl, propofol, and cisatracurium, along with uniform ventilatory and monitoring protocols. Have emergence parameters recorded immediately after discontinuation of the inhaled agent (eye opening, command following, extubation). Be evaluated in the post-anesthesia care unit using the modified Aldrete Score (MAS) and SOMCT, with predefined thresholds for recovery (MAS ≥ 9, SOMCT ≥ 20). This study aims to determine whether desflurane-due to its lower blood/gas partition coefficient-offers measurable clinical benefits in terms of rapid awakening, cognitive recovery, and overall early postoperative recovery in the geriatric population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Sep 2024

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 15, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2025

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

December 4, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 17, 2025

Completed
Last Updated

December 17, 2025

Status Verified

December 1, 2025

Enrollment Period

7 months

First QC Date

December 4, 2025

Last Update Submit

December 4, 2025

Conditions

Keywords

desfluranesevofluraneelderlygeneral anesthesiarecoverycognition

Outcome Measures

Primary Outcomes (3)

  • Time to eye opening

    Time from discontinuation to the volatile agent to eye opening

    within 3 to 24 minutes after discontinuiation of the volatile agent

  • Time to obey verbal command

    Time from discontinuation of the volatile agent to obeying verbal command

    within 5 to 40 minutes after discontinuation of the volatile agent

  • Time to extubation

    Time from discontinuation of the volatile agent to extubation

    within 6 to 30 minutes after disontinuation of the volatile agent

Secondary Outcomes (3)

  • Time to reach a Modified Aldrete Score 9 or greater

    within 10 to 48 minutes after discontinuation of the volatile agent

  • Time to discharge from the recovery room

    within 12 to 53 minutes after discontinuation of the volatile agent

  • Time to reach a SOMCT 20 or higher

    within 15 to 55 minutes from discontinuation of the volatile agent

Study Arms (2)

sevoflurane group

ACTIVE COMPARATOR

Participants receive Sevoflurane for anesthesia maintenance with a Fresh Gaz Flow of less than 1 L/min.

Drug: Sevoflurane

Desflurane group

ACTIVE COMPARATOR

Participants receive Desflurane for anesthesia maintenance with a Fresh Gaz Flow of less than 0.5 L/min.

Drug: Desflurane

Interventions

Sevoflurane used for anesthesia maintenance with a MAC of 2-3% and FGF of less than 1 L/min.

sevoflurane group

Desflurane used for anesthesia maintenance with a MAC of 4-6% and FGF of less than 0.5 L/min.

Desflurane group

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elderly patients whose ages are superior to 60 years of age \[1\].
  • Patients with an American Society of Anesthesiologists Classification (ASA) I, II or III stable (Annex 1).
  • Patients undergoing elective non-cardiac surgery under general anesthesia with tracheal intubation.
  • Patients having declined to participate in the study protocol.
  • Patients with a contraindication for minimal flow anesthesia such as hyperthermia, smoke intoxication and ketoacidosis metabolic condition (for example, anorexia nervosa).
  • Patients with history of malignant hyperthermia.
  • Patients with Psychotic disorders.
  • Patients with substance abuse.
  • Patients with severe obstructive or restrictive pulmonary disease.
  • Patients with hepatic disease.
  • Patients with end stage renal disease.
  • Patients with history of allergy to study drugs.

You may not qualify if:

  • We excluded from our study patients who presented with perioperative complication or instability requiring ICU transfer due to extubation failure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital of Charles Nicolle, Tunis, Tunis 1006

Tunis, Tunis Governorate, 1006, Tunisia

Location

Related Publications (11)

  • Kim CT, Myung W, Lewis M, Lee H, Kim SE, Lee K, Lee C, Choi J, Kim H, Carroll BJ, Kim DK. Exposure to General Anesthesia and Risk of Dementia: A Nationwide Population-Based Cohort Study. J Alzheimers Dis. 2018;63(1):395-405. doi: 10.3233/JAD-170951.

    PMID: 29614656BACKGROUND
  • Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry. 1983 Jun;140(6):734-9. doi: 10.1176/ajp.140.6.734.

    PMID: 6846631BACKGROUND
  • Jindal R, Kumra VP, Narani KK, Sood J. Comparison of maintenance and emergence characteristics after desflurane or sevoflurane in outpatient anaesthesia. Indian J Anaesth. 2011 Jan;55(1):36-42. doi: 10.4103/0019-5049.76604.

    PMID: 21431051BACKGROUND
  • Kaur A, Jain AK, Sehgal R, Sood J. Hemodynamics and early recovery characteristics of desflurane versus sevoflurane in bariatric surgery. J Anaesthesiol Clin Pharmacol. 2013 Jan;29(1):36-40. doi: 10.4103/0970-9185.105792.

    PMID: 23493107BACKGROUND
  • Saha M, Saxena KN, Wadhwa B. Comparative study of recovery of airway reflexes and cognitive function following sevoflurane versus desflurane anaesthesia. Indian J Anaesth. 2021 Apr;65(4):282-288. doi: 10.4103/ija.IJA_1219_20. Epub 2021 Apr 15.

    PMID: 34103741BACKGROUND
  • La Colla L, Albertin A, La Colla G, Mangano A. Faster wash-out and recovery for desflurane vs sevoflurane in morbidly obese patients when no premedication is used. Br J Anaesth. 2007 Sep;99(3):353-8. doi: 10.1093/bja/aem197. Epub 2007 Jul 9.

    PMID: 17621601BACKGROUND
  • White PF, Tang J, Wender RH, Yumul R, Stokes OJ, Sloninsky A, Naruse R, Kariger R, Norel E, Mandel S, Webb T, Zaentz A. Desflurane versus sevoflurane for maintenance of outpatient anesthesia: the effect on early versus late recovery and perioperative coughing. Anesth Analg. 2009 Aug;109(2):387-93. doi: 10.1213/ane.0b013e3181adc21a.

    PMID: 19608808BACKGROUND
  • Gangakhedkar GR, Monteiro JN. A prospective randomized double-blind study to compare the early recovery profiles of desflurane and sevoflurane in patients undergoing laparoscopic cholecystectomy. J Anaesthesiol Clin Pharmacol. 2019 Jan-Mar;35(1):53-57. doi: 10.4103/joacp.JOACP_375_17.

    PMID: 31057241BACKGROUND
  • Wang C, Li L, Xu H, Lv H, Zhang H. Effect of desflurane-remifentanil or sevoflurane-remifentanil on early recovery in elderly patients: a meta-analysis of randomized controlled trials. Pharmazie. 2019 Apr 1;74(4):201-205. doi: 10.1691/ph.2019.8935.

    PMID: 30940302BACKGROUND
  • Lockwood G. Theoretical context-sensitive elimination times for inhalation anaesthetics. Br J Anaesth. 2010 May;104(5):648-55. doi: 10.1093/bja/aeq051. Epub 2010 Mar 16.

    PMID: 20233751BACKGROUND
  • Wagner S, Breitkopf M, Ahrens E, Ma H, Kuester O, Thomas C, von Arnim CAF, Walther A. Cognitive function in older patients and their stress challenge using different anesthesia regimes: a single center observational study. BMC Anesthesiol. 2023 Jan 6;23(1):6. doi: 10.1186/s12871-022-01960-7.

    PMID: 36609226BACKGROUND

Related Links

MeSH Terms

Interventions

SevofluraneDesflurane

Intervention Hierarchy (Ancestors)

Methyl EthersEthersOrganic ChemicalsHydrocarbons, FluorinatedHydrocarbons, HalogenatedHydrocarbonsEthyl Ethers

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This prospective randomized single-blind trial compares desflurane versus sevoflurane for assessing early postoperative recovery and cognitive function in elderly patients undergoing elective non-cardiac surgery. Primary objectives: evaluate the time from discontinuation of the volatile agent to eye opening, response to verbal commands, and extubation. Secondary objectives include the time required to achieve a modified Aldrete Score (MAS) ≥9, post-anesthesia care unit (PACU) discharge time, and the interval to reach an SOMCT score ≥20. Inclusion criteria: patients aged over 60 years, ASA physical status I-III, scheduled for elective non-cardiac surgery under general anesthesia. Exclusion criteria: pre-existing cognitive impairment (baseline SOMCT \<20), severe hepatic or renal failure, anticipated difficult airway, emergency surgery, or refusal to participate. A total of 81 patients were randomized into two groups to receive either desflurane or sevoflurane for anesthesia maintenance.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Anesthesiology and Intensive Care Department at Charles Nicolle Hospital in Tunis

Study Record Dates

First Submitted

December 4, 2025

First Posted

December 17, 2025

Study Start

September 15, 2024

Primary Completion

April 15, 2025

Study Completion

April 15, 2025

Last Updated

December 17, 2025

Record last verified: 2025-12

Locations